Prime Medicine, Inc. (PRME)
(Delayed Data from NSDQ)
$5.61 USD
-0.04 (-0.71%)
Updated Jul 26, 2024 04:00 PM ET
After-Market: $5.60 -0.01 (-0.18%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth C Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/05/2024
Time: -- |
6/2024 | $-0.40 | 0.00% |
Earnings Summary
For their last quarter, Prime Medicine, Inc. (PRME) reported earnings of -$0.44 per share, beating the Zacks Consensus Estimate of $-0.45 per share. This reflects a positive earnings surprise of 2.22%. Look out for PRME's next earnings release expected on August 05, 2024. For the next earning release, we expect the company to report earnings of -$0.40 per share, reflecting a year-over-year increase of 14.89%.
Earnings History
Price & Consensus
Zacks News for PRME
Top 5 Small-Cap Biotechnology Stocks for a Stable Portfolio
PRME: What are Zacks experts saying now?
Zacks Private Portfolio Services